Founded in 1996, Cardinal Partners focuses on investing in seed-stage, early-stage, and later-stage companies in the healthcare, B2C, artificial intelligence, machine learning, big data, blockchain, and life sciences sectors. They work closely with scientists, consultants, and entrepreneurs to support innovation in healthcare IT, medical technology, services, and life sciences. Some of their notable portfolio companies include Vividion Therapeutics, Ivenix, and lifeIMAGE. Cardinal Partners has a preference for startups with 1-3 founders and typically invests in companies that are 4-5 years old. They have been involved in 2-6 deals per year, with an average investment size ranging from $10 million to $50 million.